Clearmind Medicine

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CMND and other ETFs, options, and stocks.

About CMND

Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. It focuses on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. 

CEO
Adi Zuloff-Shani
CEOAdi Zuloff-Shani
Employees
Employees
Headquarters
Vancouver, British Columbia
HeadquartersVancouver, British Columbia
Founded
2017
Founded2017
Employees
Employees

CMND Key Statistics

Market cap
3.94M
Market cap3.94M
Price-Earnings ratio
-0.07
Price-Earnings ratio-0.07
Dividend yield
Dividend yield
Average volume
200.05K
Average volume200.05K
High today
$2.67
High today$2.67
Low today
$2.45
Low today$2.45
Open price
$2.47
Open price$2.47
Volume
75.31K
Volume75.31K
52 Week high
$62.00
52 Week high$62.00
52 Week low
$1.74
52 Week low$1.74

Stock Snapshot

The current Clearmind Medicine(CMND) stock price is $2.64, with a market capitalization of 3.94M. The stock trades at a price-to-earnings (P/E) ratio of -0.07.

On 2026-01-20, Clearmind Medicine(CMND) stock moved within a range of $2.45 to $2.67. With shares now at $2.64, the stock is trading +7.6% above its intraday low and -1.1% below the session's peak.

Trading volume for Clearmind Medicine(CMND) stock has reached 75.31K, versus its average volume of 200.05K.

The stock's 52-week range extends from a low of $1.74 to a high of $62.00.

The stock's 52-week range extends from a low of $1.74 to a high of $62.00.

People also own

Based on the portfolios of people who own CMND. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .